Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Abc Compounding's Sani-Foam Mango pulled nationwide in ongoing FDA-classified recall

A US enforcement report entry dated 4 November 2026 shows the Delta Foremost product is under a recall tied to manufacturing-practice failings; its commercial scale is not disclosed.

04 Nov 2026 · FDA enforcement report · Regulator

Abc Compounding Co., Inc. is the manufacturer behind a recall of Delta Foremost Sani-Foam Mango, according to an entry in the US Food and Drug Administration's enforcement report dated 4 November 2026. The recall carries the reference D-0090-2027 and is still open.

The agency gives the reason as deviations from current good manufacturing practice, the baseline quality standard for making drugs in the US. The product was shipped to customers across the country, so any retrieval effort would cover the full domestic distribution chain rather than a single region.

The commercial consequences cannot be gauged from the information available. The entry as summarised does not state how much product is affected, which lots or expiry dates are covered, or when the company began the recall. It also does not describe the specific manufacturing lapses, and it does not indicate what the action might cost Abc Compounding or Delta Foremost in lost sales, returns or remediation.

By way of context, the FDA assigns a Class II label where exposure to a product could cause temporary or medically reversible harm, or where serious harm is considered unlikely. It is the middle tier of the agency's three recall categories. The text available does not cite any reports of patient harm.

Because the status is listed as ongoing, the recall has not been closed out. Any later change to the record, such as additional lot detail or a termination notice, would be the next point at which the scale of the action becomes clearer.

Why it matters

  • A manufacturing-practice shortfall alone can trigger an FDA-classified recall, so quality-system gaps carry direct commercial risk for compounders and their partners.
  • The entry gives no volumes, lots or start date, so the revenue and supply impact on Abc Compounding and Delta Foremost remains unquantified.
  • Distributors and customers holding the product should consult the full enforcement report record for lot and code details, which are not in the available text.
  • The recall remains open; regulatory affairs teams can watch for updates or a closure notice.

Official record: FDA enforcement report ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →